Manuscripts
Showing 1530 manuscripts.
Maternal HBV Viremia and Association With Adverse Infant Outcomes in Women Living With HIV and HBV
Citation
Debika Bhattacharya, Rong Guo, Chi-Hong Tseng, Lynda Emel, Ren Sun, Shih-Hsin Chiu, Lynda Stranix-Chibanda, Tsungai Chipato, Neaka Mohtashemi, Kenneth Kintu, Karim Manji, Dhayendre Moodley, Chloe Thio, Yvonne Maldonado, Judith Currier. Maternal HBV Viremia and Association With Adverse Infant Outcomes in Women Living With HIV and HBV. Pediaric Infectious Disease Journal. 2022. PMID: 33181788
Year
Journal
Pharmacokinetics and safety of early nevirapine-based antiretroviral therapy for neonates at high risk for perinatal HIV infection: a phase 1/2 proof of concept study
Citation
Theodore Ruel, Edmund Capparelli, Camlin Tierney, Bryan Nelson, Anne Coletti, Yvonne Bryson, Mark Cotton, Stephen Spector, Mark Mirochnick, Rebecca LeBlanc, Christina Reding, Bonnie Zimmer, Deborah Persaud, Mutsa Bwakura-Dangarembizi, Kimesh Naidoo, Rohan Hazra, Patrick Jean-Philippe, Ellen Chadwick. Pharmacokinetics and safety of early nevirapine-based antiretroviral therapy for neonates at high risk for perinatal HIV infection: a phase 1/2 proof of concept study. Lancet HIV. 2021. 8: e149-e157. PMID: 33242457
Year
Journal
Study
Pharmacokinetics and safety of maraviroc in neonates
Citation
Julia Rosebush, Brookie Best, Ellen Chadwick, Kevin Butler, John Moye, Elizabeth Smith, Sarah Bradford, Christina Reding, Sisinyana Mathiba, Sherika Hanley, Mariam Aziz, James Homans, Edward Acosta, William Murtaugh, Manoli Vourvahis, Lynn Mcfadyen, Katy Hayward, Mark Mirochnick, Pearl Samson, IMPAACT 2007 Study Team. Pharmacokinetics and safety of maraviroc in neonates. AIDS. 2021. 35: 419-427. PMID: 33252481
Year
Journal
Study
Impact of postpartum tenofovir-based antiretroviral therapy on bone mineral density in breastfeeding women with HIV enrolled in a randomized clinical trial
Citation
Lynda Stranix-Chibanda, Camlin Tierney, Dorothy Sebikari , Jim Aizire, Sufia Dadabhai, Admire Zanga, Cynthia Mukwasi-Kahari, Tichaona Vhembo, Avy Violari, Gerard Theron, Dhayandre Moodley , Kathleen George, Bo Fan, Markus J Sommer, Renee Browning, Lynne M Mofenson, John Shepherd, Bryan Nelson, Mary Glenn Fowler, George K Siberry , PROMISE P1084s study team. Impact of postpartum tenofovir-based antiretroviral therapy on bone mineral density in breastfeeding women with HIV enrolled in a randomized clinical trial. PLoS One. 2021. 16: e0246272. PMID: 33544759
Year
Journal
Study
Efficacy and safety of dolutegravir with emtricitabine and tenofovir alafenamide fumarate or tenofovir disoproxil fumarate, and efavirenz, emtricitabine, and tenofovir disoproxil fumarate HIV antiretroviral therapy regimens started in pregnancy (IMPAACT 2010/VESTED): a multicentre, open-label, randomised, controlled, phase 3 trial
Citation
Sean Brummel, Lauren Ziemba, Lynda Stranix-Chibanda, Katie McCarthy, Anne Coletti, Patrick Jean-Philippe, Benjamin Johnston, Chelsea Krotje, Lee Fairlie, Risa Hoffman, Paul E. Sax, Sikhulile Moyo, Nahida Chakhtoura, Jeffrey S. A. Stringer, Gaerolwe Masheto, Violet Korutaro, Haseena Cassim, Blandina Mmbaga, Esau Joao, Sherika Hanley, Lynette Purdue, Lewis Ball Holmes, Jeremiah D. Momper, Roger L. Shapiro, Navdeep Thoofer, James F. Rooney, Lisa Frenkel, K. Rivet Amico, Lameck Chinula, Judith Currier, IMPAACT 2010/VESTED study team and investigators, Shahin Lockman. Efficacy and safety of dolutegravir with emtricitabine and tenofovir alafenamide fumarate or tenofovir disoproxil fumarate, and efavirenz, emtricitabine, and tenofovir disoproxil fumarate HIV antiretroviral therapy regimens started in pregnancy (IMPAACT 2010/VESTED): a multicentre, open-label, randomised, controlled, phase 3 trial. Lancet. 2021. 397: 1276-92. PMID: 33812487
Year
Journal
Study
Pregnancy associates with alterations to the host and microbial proteome in vaginal mucosa
Citation
Christina Zuend, Nicole Tobin, Trisha Vera, Lani Kotyrba, Laura Noel-Romas, Kenzie Birse, Sarah Mutch, Fan Li, David Lee, Stuart McCorrister, Garrett Westmacott, Grace Aldrovandi, Adam Burgner. Pregnancy associates with alterations to the host and microbial proteome in vaginal mucosa. American Journal of Reproductive Immunology. 2020. 83: e13235. PMID: 32196803
Year
Journal
Effect on growth of exposure to maternal antiretroviral therapy in breastmilk versus extended infant nevirapine prophylaxis among HIV-exposed perinatally uninfected infants in the PROMISE randomized trial
Citation
Lynda Stranix-Chibanda, Camlin Tierney, Mauricio Pinilla, Kathleen George, Jim Aizire, Godwin Chipoka, Macpherson Mallewa, Megeshinee Naidoo, Teacler Nematadzira, Bangani Kusakara, Avy Violari, Tapiwa Mbengeranwa, Boniface Njau, Lee Fairlie, Gerard Theron, Mwangelwa Mubiana-Mbewe, Sandhya Khadse, Renee Browning, Mary Glenn Fowler, George K. Siberry, PROMISE Study Team. Effect on growth of exposure to maternal antiretroviral therapy in breastmilk versus extended infant nevirapine prophylaxis among HIV-exposed perinatally uninfected infants in the PROMISE randomized trial. PLoS One. 2021. 16: e0255250. PMID: 34415933
Year
Journal
Study
Pharmacokinetic Enhancement of HIV Antiretroviral Therapy During Pregnancy
Citation
Engie Salama, Ahizechukwu C Eke, Brookie M Best, Mark Mirochnick, Jeremiah D Momper. Pharmacokinetic Enhancement of HIV Antiretroviral Therapy During Pregnancy. Journal of Clinical Pharmacology. 2020. 60: 1537-1550. PMID: 32798276
Year
Journal
Study
Site-Randomized Controlled Trial of a Combined Cognitive Behavioral Therapy and a Medication Management Algorithm for Treatment of Depression Among Youth Living With HIV in the United States
Citation
Larry K Brown, Miriam Chernoff, Betsy D Kennard, Graham J Emslie, Kathryn Lypen, Sarah Buisson, Adriana Weinberg, Laura B Whiteley, Shirley Traite, Chelsea Krotje, Lauren Harriff, Ellen Townley, Amber Bunch, Murli Purswani, Ray Shaw, Stephen A Spector, Allison Agwu, David E Shapiro, IMPAACT 2002 team. Site-Randomized Controlled Trial of a Combined Cognitive Behavioral Therapy and a Medication Management Algorithm for Treatment of Depression Among Youth Living With HIV in the United States. Journal of Acquired Immune Deficiency Syndromes. 2021. 88(5): 497-505. PMID: 34483297
Year
Journal
Study
Pharmacokinetics of Tenofovir Alafenamide With Boosted Protease Inhibitors in Pregnant and Postpartum Women Living With HIV: Results From IMPAACT P1026s
Citation
Kristina M. Brooks, Mauricio Pinilla, Alice M. Stek, David E. Shapiro, Emily Barr, Irma L. Febo, Mary E. Paul, Jaime G. Deville, Kathleen George, Kevin Knowles, Kittipong Rungruengthanakit, Renee Browning, Nahida Chakhtoura, Edmund V. Capparelli, Mark Mirochnick, Brookie M. Best, IMPAACT P1026s Protocol Team. Pharmacokinetics of Tenofovir Alafenamide With Boosted Protease Inhibitors in Pregnant and Postpartum Women Living With HIV: Results From IMPAACT P1026s. Journal of Acquired Immune Deficiency Syndromes. 2022. 90: 343-350. PMID: 35195573